Vontobel Holding’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$97K Buy
+14,247
New +$107K ﹤0.01% 1149
2025
Q4
Sell
-5,000
Closed -$65.2K 1433
2025
Q3
$65.2K Hold
5,000
﹤0.01% 1314
2025
Q2
$48.8K Buy
5,000
+1,250
+33% +$13.2K ﹤0.01% 1235
2025
Q1
$46.6K Buy
3,750
+625
+20% +$8.94K ﹤0.01% 1064
2024
Q4
$48.1K Buy
3,125
+625
+25% +$11.8K ﹤0.01% 1075
2024
Q3
$57.6K Hold
2,500
﹤0.01% 1056
2024
Q2
$48.4K Buy
2,500
+812
+48% +$21.8K ﹤0.01% 1044
2024
Q1
$63.5K Buy
+1,688
New +$69.8K ﹤0.01% 1044

Other funds holding ACET

Vontobel Holding's ACET Position: Q1 2026 in Review

Vontobel Holding opened a new position in Adicet Bio (ACET) in Q1 2026: 14,247 shares worth $97K. The stake represents ﹤0.01% of the portfolio and ranks #1149 among its holdings. This is a return to the name: Vontobel Holding previously reported a position in ACET as recently as Q3 2025.

Vontobel Holding first reported a position in ACET in Q1 2024 and has held it in 8 quarters since. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Vontobel Holding held 14,247 shares of Adicet Bio worth $97K as of Q1 2026.
  • Adicet Bio was a new Vontobel Holding position in Q1 2026.
  • Adicet Bio made up ﹤0.01% of Vontobel Holding's portfolio in Q1 2026, its #1149 holding.
  • Vontobel Holding first reported a position in Adicet Bio in Q1 2024 and has held it in 8 quarters since.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.